Profiel
David Burke currently works at The Ruth Group, Inc., as Vice President, The IGB Group, as Vice President, and Sernova Biotherapeutics, Inc., as Vice President-Investor Relations from 2024.
Mr. Burke also formerly worked at Albemarle Corp., as Director-Investor Relations from 2021 to 2022, Rigel Pharmaceuticals, Inc., as Director-Investor Relations & Communications from 2018 to 2021, Dynavax Technologies Corp., as Director-IR & Corporate Communications from 2018 to 2019, and Aldeyra Therapeutics, Inc., as Head-Investor Relations.
Mr. Burke received his undergraduate degree from the University of North Carolina at Chapel Hill.
Actieve functies van David Burke
| Bedrijven | Functie | Begin |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Investor Relations Contact | 11-10-2024 |
The IGB Group
The IGB Group Miscellaneous Commercial ServicesCommercial Services Operates as an independent investor relations, advisory and strategic communications firm | President | - |
The Ruth Group, Inc.
The Ruth Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investor and public relations services | Corporate Officer/Principal | - |
Eerdere bekende functies van David Burke
| Bedrijven | Functie | Einde |
|---|---|---|
| ALBEMARLE CORPORATION | Investor Relations Contact | 01-05-2022 |
| RIGEL PHARMACEUTICALS, INC. | Investor Relations Contact | 01-01-2021 |
| DYNAVAX TECHNOLOGIES CORPORATION | Investor Relations Contact | 29-01-2019 |
| ALDEYRA THERAPEUTICS, INC. | Investor Relations Contact | - |
Opleiding van David Burke
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Albemarle Corp.
Albemarle Corp. Chemicals: SpecialtyProcess Industries Manufactures basic lithium compounds for energy storage, plastic materials and organometallic co-catalysts | Process Industries |
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
The Ruth Group, Inc.
The Ruth Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investor and public relations services | Commercial Services |
The IGB Group
The IGB Group Miscellaneous Commercial ServicesCommercial Services Operates as an independent investor relations, advisory and strategic communications firm | Commercial Services |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















